Steven Perrin serves as Executive at Eledon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Steven Perrin has executed 1 insider transactions totaling $2.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 23, 2022 involved purchasing 1,000 shares valued at $2.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 23, 2022 | ELDN | $2.6K | Purchase | 1,000 | $2.60 | Discretionary |
Steven Perrin currently holds 1,000 shares of Eledon Pharmaceuticals, Inc. (ELDN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Perrin has been a net buyer of ELDN stock. They have purchased $2.6K and sold $0 worth of shares.
Steven Perrin's most recent insider trade was on Nov 23, 2022, when they purchased 1,000 shares at $2.60 per share.
Get notified when new Form 4 filings are submitted